New Key Statistics Module, Z-Score and F-Score
NYSE:ADCT Key Ratios
| Market Cap $ M | 358.18 |
| Enterprise Value $ M | 203.96 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 5.09 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 69.00 |
| EPS (TTM) $ | -2.95 |
| Beneish M-Score | -5.38 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 4.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.37 |
| EV-to-EBITDA | -1.40 |
| PEG | -- |
| Shares Outstanding M | 82.53 |
| Net Margin (%) | -345.11 |
| Operating Margin % | -237.29 |
| Pre-tax Margin (%) | -280.94 |
| Quick Ratio | 4.73 |
| Current Ratio | 4.97 |
| ROA % (ttm) | -52.47 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -160.49 |
| Dividend Yield % | -- |
| Altman Z-Score | -5.12 |
ADCT Number of Guru Trades
ADCT Volume of Guru Trades
Gurus Latest Trades with NYSE:ADCT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:ADCT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ADC Therapeutics SA Insider Transactions
No Available Data
News about NYSE:ADCT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers